Zeroing in on Tumor-Reactive TILs
- PMID: 27590279
- DOI: 10.1158/2326-6066.CIR-16-0179
Zeroing in on Tumor-Reactive TILs
Abstract
Adoptive cell transfer of tumor-specific T cells provides an effective strategy for cancer immunotherapy. An article in this issue provides a novel approach to refine this technology by identifying tumor-reactive T cells based on frequency and PD-1 expression. Cancer Immunol Res; 4(9); 719. ©2016 AACRSee article by Ascierto et al., p. 726.
©2016 American Association for Cancer Research.
Comment on
-
Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor.Cancer Immunol Res. 2016 Sep 2;4(9):734-43. doi: 10.1158/2326-6066.CIR-16-0001. Epub 2016 Jun 28. Cancer Immunol Res. 2016. PMID: 27354337 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources